Cervical cancer is one of the only cancers that can be prevented by a vaccine. This is because around 98% of all cervical cancer cases are caused by the human papillomavirus (HPV), which implants DNA in the genome of human ...
Feb 10, 2020
0
2
Scientists at the University of East Anglia are pioneering a new way of finding the bacteria and viruses associated with cancer.
Oct 22, 2019
0
37
Papillomavirus has traditionally been considered strictly a sexually transmitted disease, but a recent study found that rabbit and mouse papillomaviruses could be transferred by blood to their respective hosts.
Sep 11, 2019
0
50
Human papilloma virus (HPV) vaccination programs have substantially reduced the number of infections and precancerous cervical lesions caused by the virus, according to a study published today in The Lancet by researchers ...
Jun 27, 2019
0
1
A vaccine against cervical and other cancers should be recommended for both men and women up to age 26, a U.S. government advisory panel decided Wednesday.
Jun 26, 2019
0
0
Cervical cancer negative for the human papilloma virus (HPV) is rare but more aggressive. It is more frequently diagnosed at advanced stages, with more metastasis and reduced survival. These are the conclusions of a study ...
Apr 18, 2019
0
1
The social stigmas and myths surrounding the human papilloma virus (HPV) could make women anxious, including raising fears about their partners' fidelity and putting them off going for cervical screening, according to research ...
Feb 12, 2019
0
1
A collaboration in Malaysia is piloting a novel cervical screening program that features the comfort of self-sampling and the ease of digital communication. Led by the University of Malaya in partnership with other universities, ...
Feb 4, 2019
0
1
Cervical cancer is the second leading cause of cancer death for Māori women aged 25–44 and Māori women are more than twice as likely as New Zealand European women to be diagnosed with, and three times more likely to die ...
Jan 23, 2019
0
1
A tumor-specific vaccine combined with an immune checkpoint inhibitor shrank tumors in one third of patients with incurable cancer related to the human papilloma virus (HPV) in a phase II clinical trial led by investigators ...
Sep 27, 2018
0
78
